DEFI Gestion
Neomed and Defi back CHF 1.3m round for Diagnoplex
Neomed and Defi Gestion have taken part in a CHF 1.3m funding round for Diagnoplex SA, a Swiss developer of diagnostics for colon cancer.
Neomed and Defi Gestion have taken part in a CHF 1.3m funding round for Diagnoplex SA, a Swiss developer of diagnostics for colon cancer.